Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q3 FY20 results · Oct–Dec 2019
Camlin Fine Sciences reported revenue from operations of ₹273.88 crore (up 13.5% from Q3 FY19) and net profit of ₹3.83 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 273.88 | 241.40 | +13.5% | 222.28 | +23.2% |
| Other income | 0.65 | 0.84 | −22.0% | 0.64 | +1.6% |
| Total income | 274.53 | 242.23 | +13.3% | 222.92 | +23.2% |
| Profit before tax | 14.25 | (1.60) | Turned profit | 8.56 | +66.5% |
| Net profit for the period | 3.83 | (0.79) | Turned profit | 7.52 | −49.1% |
| Attributable to shareholders of the company | 5.16 | (2.04) | Turned profit | 6.94 | −25.7% |
| EPS, basic (₹) | 0.43 | (0.17) | Turned profit | 0.57 | −24.6% |
| Net margin (%) | 1.4 | -0.3 | 3.4 |
Consolidated
- Filed with BSE
- 10 Feb 2020, 15:21 IST
- Board meeting
- 07 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE